Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Iu M, Ovchinnikov"'
Autor:
Iu M, Ovchinnikov, V P, Gamov
Publikováno v:
Vestnik otorinolaringologii. (4)
Autor:
Iu M, Ovchinnikov
Publikováno v:
Vestnik otorinolaringologii. (4)
Autor:
V M, Svistushkin, Iu M, Ovchinnikov, G N, Nikiforova, Z B, Bankhaeva, M V, Rudenko, Ia V, Detochka
Publikováno v:
Vestnik otorinolaringologii. (4)
The objective of this study was to analyse the efficiency and safety of the use of a holmium- YAG laser (wave length 2.09 mcm) and an erbium-activated glass-based fiber laser scalpel (wave length 1.56 mcm) in ENT-surgery. Priority methods for the sur
[Vestibular disorders in patients with otosclerosis: prevalence, diagnostic and therapeutic options]
Publikováno v:
Vestnik otorinolaringologii. (2)
A total of 177 patients with otosclerosis were selected for this study. Vestibular disorders were diagnosed in 40 (22.6%) of them. The patients were allocated to 2 groups comprising 11 and 18 subjects respectively. Patients of group 1 were given surg
Autor:
Iu M, Ovchinnikov
Publikováno v:
Vestnik otorinolaringologii. (5)
Publikováno v:
Vestnik otorinolaringologii. (3)
According to pharmacological studies, cavinton has an effect on the end links of aminoglycosides interaction with elements of the internal ear. Basing on this property, cavinton was used as prophylaxis of neurosensory hypoacusis in 118 patients aged
Publikováno v:
Vestnik otorinolaringologii. (3)
The authors review current knowledge on pathogenesis of allergic rhinosinusitis and bronchial asthma and their relations, show the role of leukotriens in development of respiratory allergy, characterize antileukotrienic medicines. Eleven patients wit
Autor:
Iu M, Ovchinnikov, A Iu, Ovchinnikov, V M, Svistushkin, G N, Nikiforova, O I, Epshteĭn, I S, Zak
Publikováno v:
Vestnik otorinolaringologii. (1)
Publikováno v:
Vestnik otorinolaringologii. (2)
Autor:
Iu M, Ovchinnikov, A A, Borodin
Publikováno v:
Vestnik otorinolaringologii. (1)
The paper reports three cases of cochlear implantation using implant Combi 40+ produced by Med-El (Austria). Short-term postoperative testing results demonstrate an appreciable progress in hearing. Changes in speech discrimination and speech producti